Predictors for incomplete response to ursodeoxycholic acid in primary biliary cholangitis. Data from a national registry of liver disease

BACKGROUND: The current standard of treatment in primary biliary cholangitis (PBC) is ursodeoxycholic acid (UDCA), although a considerable proportion of patients show incomplete response resulting in disease progression. OBJECTIVE: This study aimed to assess the prevalence of incomplete response to...

Descripción completa

Detalles Bibliográficos
Autores principales: Cortez‐Pinto, Helena, Liberal, Rodrigo, Lopes, Susana, Machado, Mariana V., Carvalho, Joana, Dias, Teresa, Santos, Arsénio, Agostinho, Cláudia, Figueiredo, Pedro, Loureiro, Rafaela, Martins, Alexandra, Alexandrino, Gonçalo, Cotrim, Isabel, Leal, Carina, Presa, José, Mesquita, Mónica, Nunes, Joana, Gouveia, Catarina, Vale, Ana Horta e, Alves, Ana Luísa, Coelho, Mariana, Maia, Luís, Pedroto, Isabel, Banhudo, António, Pinto, João Sebastião, Gomes, Marta Vargas, Oliveira, Joana, Andreozzi, Valeska, Calinas, Filipe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Hepatobiliary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8280809/
https://www.ncbi.nlm.nih.gov/pubmed/34102008
http://dx.doi.org/10.1002/ueg2.12095

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8280809/
https://www.ncbi.nlm.nih.gov/pubmed/34102008
http://dx.doi.org/10.1002/ueg2.12095

Ejemplares similares